Viewing Study NCT00285428


Ignite Creation Date: 2025-12-26 @ 10:36 AM
Ignite Modification Date: 2026-03-04 @ 9:54 PM
Study NCT ID: NCT00285428
Status: COMPLETED
Last Update Posted: 2021-08-17
First Post: 2006-01-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of hA20 (Humanized Anti-CD20) in Patients With CD20+ Non-Hodgkin's Lymphoma
Sponsor: Gilead Sciences
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: IM-T-hA20-01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: William Wegener, MD, PhD
Old Organization: Immunomedics, Inc.

Collaborators